Sex Differences in Barriers and Participation in Physical Activity During and Following Cardiac Rehabilitation

NCT ID: NCT07214350

Last Updated: 2025-12-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-02

Study Completion Date

2030-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The SPARC study will measure physical activity and functional fitness during cardiac rehabilitation, right after completion of cardiac rehabilitation, and 6 months later. This will help investigators learn if men and women maintain physical activity levels and functional fitness differently during and after they complete cardiac rehabilitation. Participants in this study will have three in-person study visits and may complete two qualitative interviews over a 10-month study period. The greatest risks during the study include physical discomfort, falling, and/or shortness of breath during the fitness testing.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Rehabilitation Heart Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adults participating in cardiac rehabilitation

Physical activity and functional fitness will be measured during cardiac rehabilitation, right after completion of cardiac rehabilitation, and 6 months later.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 18 years
* Enrolled in cardiac rehabilitation within the last month
* Own a smartphone or tablet for mobile application download

Exclusion Criteria

* Planned relocation during the study period out of the local area
* Planned medical procedure within the study period that may limit physical activity (i.e., joint replacement)
* End-stage kidney disease
* Impairment from stroke, injury, or other medical conditions that would prevent participation in or completion of the protocol
* Heart transplant
* Use of a left ventricular assist device
* Pregnant or intending to become pregnant during the study period
* Any other illness that, in the opinion of the study physician, would negatively impact or mitigate participation in or completion of the protocol
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Heart, Lung, and Blood Institute (NHLBI)

NIH

Sponsor Role collaborator

Duke University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Katherine A. Collins-Bennett, PhD

Role: PRINCIPAL_INVESTIGATOR

Duke University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Duke Center for Living

Durham, North Carolina, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Katherine A Collins-Bennett, PhD

Role: CONTACT

919-479-2368

Johanna L. Johnson, MS

Role: CONTACT

919-660-6766

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Katherine A Collins-Bennett, PhD

Role: primary

919-479-2368

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1K01HL177266-01A1

Identifier Type: NIH

Identifier Source: secondary_id

View Link

Pro00118596

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.